Factor | No. Of patients | n (%) of outcomes | P-value |
---|---|---|---|
Gender | 542 | 0.043 | |
Male | 217 | 9 (4.1) | |
Female | 325 | 28 (8.6) | |
Age (years) | 542 | 0.465 | |
16–44 | 153 | 9 (5.9) | |
45–64 | 292 | 20 (6.8) | |
65–74 | 68 | 4 (5.9) | |
75+ | 29 | 4 (13.8) | |
BMI (kg/m2) | 542 | 0.422 | |
< 20 | 29 | 1(3.4) | |
20–24.9 | 183 | 8 (4.4) | |
25–29.9 | 176 | 16 (9.1) | |
30.0–34.9 | 102 | 9 (8.8) | |
35–39.9 | 32 | 1 (3.1) | |
40–44.9 | 16 | 2 (12.5) | |
45–49.9 | 3 | 0 (0) | |
50–54.9 | 1 | 0 (0) | |
ASA class | 539 | 0.226 | |
1 | 176 | 9 (5.1) | |
2 | 228 | 13 (5.7) | |
3–4 | 135 | 13 (9.6) | |
Cardiovascular disease | 542 | 0.96 | |
yes | 203 | 14 (6.9) | |
no | 339 | 23 (6.8) | |
Anticoagulant | 541 | 0.683 | |
no | 525 | 36 (6.9) | |
warfarin | 8 | 1 (12.5) | |
aspirin | 6 | 0 (0) | |
NOAC | 2 | 0 (0) | |
Diabetes | 542 | 0.17 | |
yes | 61 | 7 (11.5) | |
no | 481 | 30 (6.2) | |
Pulmonary disease | 542 | 0.413 | |
yes | 60 | 2 (3.3) | |
no | 482 | 35 (7.3) | |
Sleep apnea | 542 | 0.386 | |
yes | 20 | 0 (0) | |
no | 522 | 37 (7.1) | |
Migraine/headache | 542 | 0.576 | |
yes | 12 | 1 (8.3) | |
no | 530 | 36 (6.8) | |
Psychiatric condition | 542 | 0.512 | |
yes | 41 | 4 (9.8) | |
no | 501 | 33 (6.6) | |
Meniere/vertigo | 542 | 1 | |
yes | 3 | 0 (0) | |
no | 539 | 37 (6.9) | |
Immunosuppression | 542 | 0.639 | |
yes | 20 | 2 (10.0) | |
no | 522 | 35 (6.7) | |
Other underlying medical condition | 542 | 0.837 | |
yes | 118 | 7 (5.9) | |
no | 424 | 30 (7.1) | |
Smoking status | 534 | 0.549 | |
no | 378 | 22 (5.8) | |
yes | 140 | 12 (8.6) | |
quit | 12 | 1 (8.3) | |
sometimes | 4 | 0 (0) |